2025
-
Panelists Explain ACR’s Expanding JIA Guidelines
Experts from the ACR’s juvenile idiopathic arthritis (JIA) guideline team, including Susan Shenoi, MBBS, MS, RhMSUS, reviewed key recommendations and changes in response to new therapeutic advances and emerging challenges. The now 15 recommendations for systemic JIA, for example, reflect greater stratification based on clinical…
-
Hench Lecture Traces IgG4-RD History, Quest for Therapies
While honoring rheumatology pioneer Philip Hench, John Stone, MD, MPH, discussed the groundbreaking work that has furthered the understanding and treatment of IgG4-related disease, including the approval of a monoclonal antibody that depletes CD19-positive B cells for use in adults.
-
FDA Reviews New Approvals, Safety Concerns for Rheumatologic Drugs
During ACR Convergence 2025, representatives from the U.S. Food and Drug Administration detailed the latest approvals of rheumatologic drugs, along with safety updates and considerations for T cell engagers.
-
FDA Pediatric Rheumatology Update Reviews New Drug Approvals
Emily C. Gotschlich, MD, gave an overview of several new indications for pediatric rheumatology, including in pediatric psoriatic arthritis, pediatric lupus nephritis, and systemic juvenile idiopathic arthritis. Most approvals leveraged an extrapolation approach, allowing efficacy data from adult populations to support pediatric indications when disease…
-
Experts Share Clinical Pearls for Recognizing and Managing POTS and Overlapping Syndromes
Speakers, including Brittany Adler, MD, discussed how postural orthostatic tachycardia syndrome (POTS) and related autonomic disorders have emerged as increasingly prevalent and complex conditions, as well as the role of physical therapy in POTS management.
-
Presenters Discuss Oral Manifestations of SSc and Sjögren’s Disease
Better oral health translates into better rheumatic health for patients living with both of these conditions, explained Natalia Trehan, DMD, one of the featured experts in a session on the orofacial complications of systemic sclerosis and Sjögren’s disease.
-
Investigators Explore Sex Hormone Modulation of Immune Responses in Autoimmunity
Autoimmune diseases predominantly affect more females than males, but the underlying significance of some of the immunological differences between the sexes is less clearly defined. Experts, including Petter Brodin, MD, PhD, explored the role of sex hormones in immune responses and autoimmunity.
-
ARP Distinguished Lecture Illuminates Participatory Research
Susan Murphy, OT, ScD, explained how leveraging participatory research methods and positioning patients and community members as essential co-creators rather than passive recipients of medical interventions can lead to meaningful collective health solutions for complex medical challenges.
-
Klemperer Lecturer Recounts New Ideas for RA Pathogenesis, Progression, and Treatment
In the Monday lecture, Michael Brenner, MD, discussed new paradigms in the immunopathogenesis of rheumatoid arthritis and other autoimmune diseases that come from taking an “unbiased” approach.
-
International Panel Explores Emerging Roles for AI in Rheumatology Imaging
Ali Guermazi, MD, PhD, MSc, was among the experts discussing how artificial intelligence (AI) is changing imaging for the diagnosis and management of rheumatic diseases.